Identifikatoren & physikalische Daten
| CAS No. | 15132-04-4 |
|---|
| Summenformel | C2H6AsO2- |
|---|
| Durchschnittliche Molmasse | 136,99 g/mol |
|---|
| Monoisotopische Masse | 136,95892451 g/mol |
|---|
| SMILES | C[As](C)(=O)[O-] |
|---|
| InChIKey | OGGXGZAMXPVRFZ-UHFFFAOYSA-M |
|---|
| PubChem CID | 167250 |
|---|
| ChEBI | CHEBI:16223 |
|---|
| DTXSID | DTXSID60164758 |
|---|
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 40,1 |
|---|
| H-Brücken-Donoren | 0 |
|---|
| H-Brücken-Akzeptoren | 2 |
|---|
| Frei drehbare Bindungen | 0 |
|---|
| Schwere Atome | 5 |
|---|
| Formalladung | -1 |
|---|
| Komplexität | 53,8 |
|---|
Sicherheit & Vorschriften
| Treatment | Arsenic poisoning can be treated by chelation therapy, using chelating agents such as dimercaprol, EDTA or DMSA. Charcoal tablets may also be used for less severe cases. In addition, maintaining a diet high in sulfur helps eliminate arsenic from the body. (L20) |
|---|
| Gesundheitliche Auswirkungen | Arsenic poisoning can lead to death from multi-system organ failure, probably from necrotic cell death, not apoptosis. Arsenic is also a known carcinogen, especially in skin, liver, bladder and lung cancers. (T1, L20) |
|---|
| Expositionspfade | Oral (L2)inhalation (L2)dermal (L2) |
|---|
| Toxizitätsübersicht | Arsenic and its metabolites disrupt ATP production through different mechanisms. At the level of the citric acid cycle, arsenic inhibits the pyruvate dehydrogenase and uncouples the oxidative phosphorylation by competing with phosphate. This leads to inhibition of energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is increased, leading to oxidative stress due to the formation of reactive oxygen species. Arsenic's carginogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17) |
|---|
| Signs and Symptoms | Exposure to lower levels of arsenic can cause nausea and vomiting, decreased production of red and white blood cells, abnormal heart rhythm, damage to blood vessels, and a sensation of “pins and needles” in hands and feet. Breathing high levels of inorganic arsenic can provoque sore throat or irritated lungs. Arsenic also affects the brain, causing neurological disturbances such as headaches, confusion, and drowsiness. (A1) |
|---|
| Carcinogen Classification | 2B, possibly carcinogenic to humans. (L135) |
|---|
| Toxicity Data | LD50: 644 mg/kg (Oral, Rat) (T14)
LD50: 720 mg/kg (Intraperitoneal, Rat) (T32) |
|---|
